(Q34839838)

4 August 2017

1 reference

6 August 2019

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States (English)

1 reference

pharmaceutical preparation

4 August 2017

1 reference

6 August 2019

0 references

Sabine Vogler

1

1 reference

4 August 2017

Claudia Habl

series ordinal

2

1 reference

4 August 2017

Martina Bogut

series ordinal

3

1 reference

4 August 2017

Luka Voncina

series ordinal

4

1 reference

4 August 2017

1 April 2011

1 reference

4 August 2017

15 April 2011

1 reference

6 August 2019

Croatian Medical Journal

2 references

4 August 2017

6 August 2019

52

1 reference

4 August 2017

2

1 reference

4 August 2017

183-197

1 reference

Creative Commons Attribution 2.5 Generic

4 August 2017

1 reference

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment

6 August 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Impact of European pharmaceutical price regulation on generic price competition: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Regulating medicines in Croatia: five-year experience of Agency for Medicinal Products and Medical Devices

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Developing competitive and sustainable Polish generic medicines market

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

The effect of regulation on pharmaceutical revenues: experience in nineteen countries

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Essential medicines and human rights: what can they learn from each other?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Croatian healthcare system in transition, from the perspective of users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

The concept of essential medicines: lessons for rich countries

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Croatian pharmaceutical sector reform project: rational drug use.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Overview of the European regulatory approval system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Encouraging the use of generic medicines: implications for transition economies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Comparative approaches to pharmaceutical price regulation in the European Union.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Out-of-pocket payments for health care in Croatia: implications for equity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Supply and regulation of medicines

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Cross-national price differences for pharmaceuticals: how large, and why?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Reform of health insurance in Croatia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3081217

Privatization in the health care system of Croatia: effects on general practice accessibility

26 October 2018

1 reference

12 December 2020

The role of economic evaluation in the pricing and reimbursement of medicines

1 reference

12 December 2020

Organization of health care in Croatia: needs and priorities

1 reference

12 December 2020

International price comparisons for pharmaceuticals. Measurement and policy issues

1 reference

12 December 2020

The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s

1 reference

12 December 2020

An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom

1 reference

12 December 2020

The increasingly complex fourth hurdle for pharmaceuticals

1 reference

12 December 2020

Role of budget impact in drug reimbursement decisions

1 reference

12 December 2020

Generic medicine pricing in Europe: current issues and future perspective

1 reference

12 December 2020

Pricing and reimbursement of pharmaceuticals in the Baltic States

1 reference

12 December 2020

Identifiers

DOI

10.3325/CMJ.2011.52.183

1 reference

4 August 2017

1 reference

4 August 2017

1 reference